1. Verma, Pratibha, Kumar, Ashutosh, Goswami, Chandan. 2010. TRPV4-mediated channelopathies. In Channels (Austin, Tex.), 4, 319-28. doi:. https://pubmed.ncbi.nlm.nih.gov/20676052/
2. Liu, Na, Bai, Liping, Lu, Zhipeng, Yan, Fang, Bai, Jie. 2022. TRPV4 contributes to ER stress and inflammation: implications for Parkinson's disease. In Journal of neuroinflammation, 19, 26. doi:10.1186/s12974-022-02382-5. https://pubmed.ncbi.nlm.nih.gov/35093118/
3. Jiang, Yangfu, Zhang, Hongying, Wang, Jiao, Luo, Ting, Hua, Hui. 2022. Targeting extracellular matrix stiffness and mechanotransducers to improve cancer therapy. In Journal of hematology & oncology, 15, 34. doi:10.1186/s13045-022-01252-0. https://pubmed.ncbi.nlm.nih.gov/35331296/
4. Plant, T D, Strotmann, R. . TRPV4. In Handbook of experimental pharmacology, , 189-205. doi:. https://pubmed.ncbi.nlm.nih.gov/17217058/
5. Choi, Jae Eun, Di Nardo, Anna. 2018. Skin neurogenic inflammation. In Seminars in immunopathology, 40, 249-259. doi:10.1007/s00281-018-0675-z. https://pubmed.ncbi.nlm.nih.gov/29713744/
6. Li, Juan, Wen, Amy M, Potla, Ratnakar, Levy, Oren, Ingber, Donald E. 2019. AAV-mediated gene therapy targeting TRPV4 mechanotransduction for inhibition of pulmonary vascular leakage. In APL bioengineering, 3, 046103. doi:10.1063/1.5122967. https://pubmed.ncbi.nlm.nih.gov/31803860/